Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPE/6838 stock hub

TPE/6838 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPE/6838is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.1B

Taiwan Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPE/6838

In the news

Latest news · TPE/6838

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-5.6

P25 -16.2P50 0.3P75 9.8

ROIC-7

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPE/6838 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

163

Groups with data

Currency

TWD

Showing 163 of 163 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees Change	2%
Employees Change Percent	25
Enterprise value	TWD 2.6B
Exchange	Taiwan Stock Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Last refreshed	2026-05-10
Market cap	TWD 4.1B
Price	TWD 26.9
Price currency	TWD
Sector	Healthcare
Sic	2834
Symbol	tpe/6838
Website	https://www.formosapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.06%
EV Earnings	-31.68x
EV/FCF	-25.05x
EV/Sales	278.78x
FCF yield	-2.6%
P/B ratio	2.79x
P/S ratio	427.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-16.83%
Gross Profit	TWD -1.6M
Gross Profit Growth Q	-80.87%
Net Income	TWD -83.6M
Pretax Margin	-884.72%
ROA	-5.1
Roa5y	-19.23
ROCE	-8.96
ROE	-5.56
Roe5y	-58.02
ROIC	-6.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	10.03%
Cagr3y	-23.63%
Revenue Growth	-93.38x
Revenue Growth Q	-45.28x
Revenue Growth3 Y	93.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0
Assets	TWD 2.1B
Cash	TWD 1.4B
Current Assets	TWD 1.5B
Current Liabilities	TWD 166.4M
Debt	TWD 27M
Debt Equity	TWD 0.02
Debt FCF	TWD -0.26
Equity	TWD 1.5B
Interest Coverage	-351.8
Liabilities	TWD 614.1M
Long Term Assets	TWD 555.3M
Long Term Liabilities	TWD 447.6M
Net Cash	TWD 1.4B
Net Cash By Market Cap	TWD 34.84
Net Cash Growth	-12.67%
Net Debt Equity	TWD -0.97
Tangible Book Value	TWD 994.3M
Tangible Book Value Per Share	TWD 6.59
WACC	8.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.11
Inventory Turnover	3.14
Net Working Capital	TWD -85.7M
Quick ratio	8.82
Working Capital	TWD 1.3B
Working Capital Turnover	TWD 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	10.02%
200-day SMA	29.1
3Y total return	-55.46%
50-day SMA	27.86
50-day SMA vs 200-day SMA	50under200
All Time High	70
All Time High Change	-61.57%
All Time High Date	2022-08-22
All Time Low	21.55
All Time Low Change	24.83%
All Time Low Date	2025-04-09
ATR	0.94
Beta	0.73
Beta1y	0.52
Beta2y	0.66
Ch YTD	1.89
High	27.15
High52	43.45
High52 Date	2025-06-23
High52ch	-38.09%
Low	26.65
Low52	24.25
Low52 Date	2025-05-12
Low52ch	10.93%
Ma50ch	-3.45%
Price vs 200-day SMA	-7.54%
RSI	40.38
RSI Monthly	39.43
RSI Weekly	45.26
Sharpe ratio	0.44x
Sortino ratio	0.96
Total Return	-7.22%
Tr YTD	1.89
Tr1m	-12.38%
Tr1w	-4.1%
Tr3m	-2.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -170.6M
Operating margin	-1,796.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	83,830,603%
Net Borrowing	-6,126,000
Shares Insiders	0.95%
Shares Institutions	9.04%
Shares Out	150,977,000
Shares Qo Q	0%
Shares Yo Y	7.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -106M
Average Volume	221,331.2x
Bv Per Share	9.65
CAPEX	TWD -10M
Ch1m	-12.38
Ch1w	-4.1
Ch1y	10.02
Ch3m	-2.18
Ch3y	-56.75
Ch6m	-2.36
Change	0.75%
Change From Open	0.75
Close	26.7
Days Gap	0
Depreciation Amortization	42,166,000
Dollar Volume	3,008,334.6
Earnings Date	2026-05-08
EBIT	TWD -170.6M
EBITDA	TWD -128.4M
EPS	TWD -0.55
F Score	1
FCF	TWD -105.7M
FCF EV Yield	-3.99x
FCF Per Share	TWD -0.7
Financing CF	-6,126,000
Fiscal Year End	December
Founded	2,010
Goodwill	30,544,000
Income Tax	TWD -431,000
Investing CF	-68,290,000
Is Primary Listing	1
Last Earnings Date	2025-11-24
Last Report Date	2025-12-31
Ma150	28.14
Ma150ch	-4.39%
Ma20	28.89
Ma20ch	-6.87%
Net CF	-184,000,000
Open	26.7
Position In Range	50
Ppne	43,563,000
Price Date	2026-05-08
Ptbv Ratio	4.08
Relative Volume	0.51x
Revenue	9,495,000x
SBC By Revenue	3.74x
Share Based Comp	355,000
Tax By Revenue	-4.54x
Tr6m	-2.36%
Volume	111,834
Z Score	3.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPE/6838 pay a dividend?

Capital-return profile for this ticker.

Performance

TPE/6838 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPE/6838?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.0%

Share of float held by funds and institutions

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+7.2%

Negative means the company is buying back shares.

Technical

TPE/6838 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.4

Neutral momentum band

Price vs 200-day MA

-7.5%

50/200-day relationship not available

Beta (5Y)

0.73

Less volatile than the market

Sharpe ratio

0.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPE/6838

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/6838 stock rating?

tpe/6838 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/6838 analysis?

The full report lives at /stocks/tpe/6838/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/6838?

The latest report frames tpe/6838 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/6838 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.